Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Recruiting
Observational Study
Retinopathy of Prematurity (ROP)
ROP Examination
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 24 Weeks – 34 Weeks
- Sex
- Any
- Study type
- Observational
- Participants needed
- 90 (estimated)
- Sponsor
- Vanderbilt University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify diseas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
Exclusion Criteria:
* Infants surgically treated for ROP
* Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary…
Contacts